Bacterial degradation of growth factors

Journal of Applied Research

Volumn 3, Issue 1, 2003, Pages 35-40

  Payne, Wyatt G ^a,b   Wright, Terry E ^a,b   Ko, Francis ^a   Wheeler, Chad ^a,b   Wang, Xue ^a   Robson, Martin C ^a,b  

^a Bay Pines VA Medical Center   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Bacterial degradation; Growth factors; Matrix metalloproteinases; Wound healing

Indexed keywords

BACTERIAL ENZYME; BASIC FIBROBLAST GROWTH FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; KERATINOCYTE GROWTH FACTOR; MATRIX METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; BACTERIUM; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; ENZYME ACTIVITY; ESCHERICHIA COLI; IN VITRO STUDY; MICROBIAL DEGRADATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; TIME SERIES ANALYSIS;

EID: 0042978821     PISSN: 1537064X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Robson MC: The role of growth factors in the healing of chronic wounds. Wound Rep Regen 5:12-17, 1997.
2. Stadelmann WK, Digenis AG, Tobin GR: Physiology and healing dynamics of chronic cutaneous wounds. Am J Surg 176(Suppl 2A):26S-38S, 1998.
3. Robson MC, Mustoe TA, Hunt TK: The future of recombinant growth factors in wound healing. Am J Surg 176(Suppl 2A):80S-82S, 1998.
4. Schultz GS, Mast BA: Molecular analysis of the environment of healing and chronic wounds: Cytokines, proteases, and growth factors. Wounds 10(Suppl F):1F-9F, 1998.
5. Tarnuzzer RW, Schultz GS: Biochemical analysis of acute and chronic wound environments. Wound Rep Regen 4:321-325, 1996.
6. Robson MC: Exogenous growth factor application effect on human wound healing. Prog Derm 30:1-6, 1996.
7. Robson MC, Stenberg BD, Heggers JP: Wound healing alterations caused by infection. Clin Plast Surg 17:485-492, 1990.
8. Robson MC: Treating bacterial infections in chronic wounds. Contemp Surg Suppl:9-11, 2000.
9. Yager DR, Chen SM, Ward SI, et al: Ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitors. Wound Rep Regen 5:23-32, 1997.
10. Robson MC: Wound infection: A failure of wound healing caused by an imbalance of bacteria. Surg Clin North Am 77:3 7-650, 1997.
11. Stadelmann WK, Digenis AG, Tobin GR: Impediments to wound healing. Am J Surg 176 (Suppl 2A):39S-47S, 1998.
12. Hayward P, Hokanson J, Heggers J, et al: Fibroblast growth factor reverses the bacterial retardation of wound cantraction. Am J Surg 163:288-293, 1992.
13. Kuhn MA, Page L, Nguyen K, et al: Basic fibroblast growth factor in a carboxymethylcellulose vehicle reverses the bacterial retardation of wound contraction. Wounds 13:73-80, 2001.
14. Robson MC, Hill DP, Smith PD, et al: Sequential cytokine therapy for pressure ulcers; clinical and mechanistic responses. Ann Surg 231:600-611, 2000.
15. Robson MC, Phillips LG, Cooper DM, et al: Safety and effect of transforming growth factor beta-2 for treatment of venous stasis ulcers. Wound Rep Regen 3:157-167, 1995.
16. Robson MC, Phillips LG, Thomason A, et al: Recombinant human platelet-derived growth factor-bb for the treatment of chronic pressure ulcers. Ann Plast Surg 29:193-201,1992.
17. Robson MC, Phillips LG, Lawrence WT, et al: The safety and effect of topically applied recombinant basic fibroblast growth factor on the healing of chronic pressure sores. Ann Surg 216(4):401-408, 1992.
18. Robson MC, Smith PD: Topical use of growth factors to enhance healing, in Cutaneous Wound Healing. Falanga V, ed. London: Martin Dunitz Limited, 2001:379-398.
19. Lazarus GS, Cooper DM, Knighton DR, et al: Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Derm 130:489-493, 1994.
20. Bennett NF, Schultz GS: Growth factors and wound healing: Part II. Role in normal and chronic wound healing. Am J Surg 166:74-81, 1993.
21. Mast BA, Schultz GS: Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Rep Regen 4:411-420, 1996.
22. VandeBerg JD, Rudolph R: Cultured myofibroblasts: A useful model to study wound contraction and pathological contracture. Ann Plast Surg 2:111-120, 1985.
23. Robson MC, Phillips TJ, Falanga V, et al: Randomized trial of topically applied repifermin (recombinant human keratinocyte growth factor-2) to accelerate wound healing in venous ulcers. Wound Rep Regen 9:347-352, 2001.